185 related articles for article (PubMed ID: 26100380)
1. Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis.
Akova Budak B; Baykara M; Kıvanç SA; Yilmaz H; Cicek S
Cutan Ocul Toxicol; 2016; 35(2):126-30. PubMed ID: 26100380
[TBL] [Abstract][Full Text] [Related]
2. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
Tu EY; Jain S
Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections.
Shibata Y; Yamagishi Y; Mikamo H; Kato H; Nishiyama N; Asai N; Koizumi Y; Matsuura K; Suematsu H; Hagihara M
J Infect Chemother; 2018 Sep; 24(9):695-701. PubMed ID: 29807867
[TBL] [Abstract][Full Text] [Related]
4. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.
Sipahi OR; Bardak-Ozcem S; Turhan T; Arda B; Ruksen M; Pullukcu H; Aydemir S; Dalbasti T; Yurtseven T; Sipahi H; Zileli M; Ulusoy S
Surg Infect (Larchmt); 2013 Aug; 14(4):357-62. PubMed ID: 23672240
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
[TBL] [Abstract][Full Text] [Related]
7. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.
Kingsley J; Mehra P; Lawrence LE; Henry E; Duffy E; Cammarata SK; Pullman J
J Antimicrob Chemother; 2016 Mar; 71(3):821-9. PubMed ID: 26679243
[TBL] [Abstract][Full Text] [Related]
9. Linezolid for the treatment of complicated skin and skin structure infections in children.
Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
[TBL] [Abstract][Full Text] [Related]
10. Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Beibei L; Yun C; Mengli C; Nan B; Xuhong Y; Rui W
Int J Antimicrob Agents; 2010 Jan; 35(1):3-12. PubMed ID: 19900794
[TBL] [Abstract][Full Text] [Related]
11. Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials.
An MM; Shen H; Zhang JD; Xu GT; Jiang YY
Int J Antimicrob Agents; 2013 May; 41(5):426-33. PubMed ID: 23537580
[TBL] [Abstract][Full Text] [Related]
12. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
13. Improved Outcome of Pythium Keratitis With a Combined Triple Drug Regimen of Linezolid and Azithromycin.
Sane SS; Madduri B; Mohan N; Mittal R; Raghava JV; Fernandes M
Cornea; 2021 Jul; 40(7):888-893. PubMed ID: 32947406
[TBL] [Abstract][Full Text] [Related]
14. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
15. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
[TBL] [Abstract][Full Text] [Related]
17. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with linezolid in the treatment of resistant gram-positive infections.
Antony SJ; Diaz-Vasquez E; Stratton C
J Natl Med Assoc; 2001 Oct; 93(10):386-91. PubMed ID: 11688919
[TBL] [Abstract][Full Text] [Related]
19. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
Tsoulas C; Nathwani D
Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913
[TBL] [Abstract][Full Text] [Related]
20. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
Sharma V; Sharma S; Garg P; Rao GN
Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
